STING1 and hypoparathyroidism-retardation-dysmorphism syndrome: Furthermore, JPI-547 exhibited specific immune modulation in cancer cells with HRD, likely through activation of the cGAS-STING pathway, which is associated with increased tumor immunogenicity and potential responsiveness to immune checkpoint inhibitors.